Pharmafile Logo
Pharmafocus logo
Advanced Search
bi_microparts_image

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018
Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …

News
david_kendall

MannKind entices Lilly VP to CMO role

February 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …

Appointment
gsk_wall

SFO bribery investigation into GSK opens old wounds

February 9, 2018
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

A small titbit of information was buried within GSK’s financials this week, which threatens to bring up old news that …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …

News
fuji

Fujifilm partners with Takeda, stepping into regenerative medicine

February 9, 2018
Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical

Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …

News

FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer

February 9, 2018
Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma

Johnson & Johnson has announced that Zytiga (abiraterone acetate) in combination with prednisone has been awarded FDA approval in the …

News
teva_copy

Migraine drug bad news hits a weakened Teva

February 9, 2018
Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical

The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …

News
peter_goldschmidt_web

Stada poaches Novartis exec for fifth CEO in two years

February 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …

Appointment
bob_hugin1

Celgene Executive Chairman Bob Hugin retires

February 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fresh from its acquisition of Juno Therapeutics, Celgene announced that its Executive Chairman Bob Hugin was to retire effective 5 …

Appointment
online_feature_image

New Year, new goals

February 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …

Feature
facilities_lg06

Dr Reddy’s hit by yet another recall, of 80,000+ bottles

February 8, 2018
Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical

Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …

News
gilead-sciences

FDA approves Gilead’s Biktarvy for HIV as Viiv Healthcare launches patent lawsuit

February 8, 2018
Sales and Marketing Biktarvy, FDA, GSK, Gilead, HIV, Pfizer, Shionogi, US, ViiV Healthcare, descovy, pharma

Gilead has announced that its daily single-tablet therapy Biktarvy has received FDA approval for HIV-1 infection.

News
novartis_window

Novartis tastes own medicine, Advair generic delayed

February 8, 2018
Sales and Marketing FDA, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis had not been frontrunner to receive approval for its generic version of GSK’s Advair – lagging behind Mylan’s generic …

News

Theravance seals potential $1bn deal with J&J

February 8, 2018
Sales and Marketing Johnson & Johnson, Theravance Biopharma, biotech, drugs, pharma, pharmaceutical

The JAK inhibitor field is beginning to heat up – AbbVie is soon to enter Phase 3 with its predicted …

News
biogen_idec_hillerod_2008

Biogen halts Tysabri trial after failure in acute ischemic stroke

February 8, 2018
Research and Development Biogen, Tysabri, multiple sclerosis, pharma, stroke, trial failure

Biogen has halted its investigation into the efficacy of its humanised monoclonal antibody Tysabri (natalizumab) in the treatment of acute …

News
kenji

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …

Appointment
arcturus_joseph-e-payne

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …

Appointment

J&J’s apalutamide shows strength in non-metastatic prostate cancer

February 7, 2018
Research and Development J&J, JJ, Johnson & Johnson, pharma, prostate cancer

Johnson & Johnson unveiled new data at the ASCO Genitourinary Cancer symposium which demonstrated that its androgen receptor antagonist apalutamide …

News
array_biopharma

Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018
Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …

News
allergan

Allergan bolsters skincare portfolio with Elastagen acquisition for $95 million

February 7, 2018
Research and Development, Sales and Marketing Allergan, Elastagen, M&A, MA, pharma

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026